Terug
Dagbereik
€ 3,52
€ 3,72
52-Weeksbereik
€ 1,11
€ 6,94
Volume
2.058.709
50D / 200D Gem.
€ 3,86
/
€ 3,93
Vorige Slotkoers
€ 3,52
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -3,2 | 0,4 |
| P/B | 5,4 | 2,9 |
| ROE % | -146,8 | 3,7 |
| Net Margin % | -4342,4 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 1,0 | 0,2 |
Koersdoel Analisten
Hold
€ 17,25
+381.8%
Low: € 12,00
High: € 23,00
Forward WPA
-€ 0,91
Omzet Sch.
22 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 0,78
-€ 2,06 – -€ 0,07
|
60 M | 6 |
| FY2029 |
-€ 0,88
-€ 2,33 – -€ 0,08
|
19 M | 6 |
| FY2028 |
-€ 0,79
-€ 1,10 – -€ 0,59
|
48 M | 8 |
Belangrijkste Punten
Negative free cash flow of -167,10M
PEG of 0,14 suggests growth is underpriced
Capital intensive — 97,82% of revenue goes to capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)55,28%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-146,81%
ROIC-65,85%
Net Margin-4342,44%
Op. Margin-4498,06%
Veiligheid
Debt / Equity
0,96
Current Ratio4,84
Interest Coverage0,00
Waardering
P/E Ratio
-3,21
P/B Ratio5,35
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 55,28% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,63M | Net Income (TTM) | -201,14M |
| ROE | -146,81% | ROA | -58,69% |
| Gross Margin | -58,05% | Operating Margin | -4498,06% |
| Net Margin | -4342,44% | Free Cash Flow (TTM) | -167,10M |
| ROIC | -65,85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,96 | Current Ratio | 4,84 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3,21 | P/B Ratio | 5,35 |
| P/S Ratio | 139,55 | PEG Ratio | 0,14 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 646,38M | Enterprise Value | 699,77M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,63M | 2,98M | 0,0 | 0,0 | 0,0 |
| Net Income | -201,14M | -195,88M | -198,13M | -121,82M | -165,37M |
| EPS (Diluted) | -1,35 | -1,65 | -2,18 | -1,46 | -1,92 |
| Gross Profit | -2,69M | 2,98M | 0,0 | 0,0 | 0,0 |
| Operating Income | -208,35M | -202,47M | -204,79M | -116,54M | -84,47M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 342,73M | 297,51M | 193,85M | 360,31M | 301,86M |
| Total Liabilities | 221,87M | 144,36M | 60,78M | 44,04M | 62,30M |
| Shareholders' Equity | 120,87M | 153,15M | 133,07M | 316,27M | 239,56M |
| Total Debt | 116,43M | 40,79M | 13,63M | 28,75M | 10,41M |
| Cash & Equivalents | 63,03M | 182,48M | 41,57M | 187,62M | 185,42M |
| Current Assets | 181,29M | 211,89M | 142,98M | 296,62M | 270,58M |
| Current Liabilities | 37,45M | 37,96M | 56,42M | 26,71M | 57,98M |